FDA approves 3rd COVID-19 vaccine jab for immunocompromised people
Category: #health  By Mateen Dalal  Date: 2021-08-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

FDA approves 3rd COVID-19 vaccine jab for immunocompromised people

The U.S. FDA (Food and Drug Administration) has revised the emergency use authorizations (EUA) status of the Pfizer and Moderna Covid-19 vaccines to permit people with weakened immune systems to receive its third dose.

The move comes after a panel of CDC experts gathered in July and advised higher doses for immunocompromised adults.

Doctors believe it's becoming increasingly evident that many of these people are still vulnerable to Covid after vaccination because their immune systems may not generate a strong reaction to the doses.

According to the CDC, around 2.7% of adults in the United States are immunocompromised. It is uncertain which groups will be covered under the FDA's forthcoming action. Organ transplant recipients, cancer patients, and HIV patients are just a few examples of immunocompromised patients.

For example, organ transplant recipients are required to take medications to lower their immune systems response so that their bodies can accept new organs. Yet, after being vaccinated, most of these patients never produced antibodies to the coronavirus, claims a study. The others merely created minimal defenses.

According to that study conducted by Johns Hopkins University, the third dose of vaccination increased the immunity levels of such cases.

Notably, the emergency use authorization excludes fully vaccinated people, otherwise healthy people. Both the Pfizer and Moderna vaccines are highly successful in reducing hospitalization and death in these individuals.

The CDC advisory group is scheduled to meet Friday, where it may vote on whether to recommend the third shot for immunocompromised people officially. The panel must give its approval before doctors can start recommending larger doses.

Such a vote is held after the FDA takes regulatory action, such as the expected adjustment to the emergency use authorization.

The Mississippi Department of Health advised that immunocompromised persons take an additional vaccine shot, even though federal health officials have not yet signed on it.

Source Credit - https://www.nbcnews.com/health/health-news/fda-poised-ok-third-vaccine-dose-immune-compromised-people-n1276602

 

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Saepio, Echoworx partner to deliver Next-Gen security solutions
Saepio, Echoworx partner to deliver Next-Gen security solutions
By Mateen Dalal

Saepio Information Security, a market leader in statement encryption and cloud-based email, has reportedly announced its collaboration with Echoworx to offer next-generation safe delivery of sensitive and secret information to any email receiver...

Ather Energy raises $250 million to stay ahead in competition
Ather Energy raises $250 million to stay ahead in competition
By Mateen Dalal

Electric scooter producer Ather Energy has reportedly secured $250 million in a new funding round. As per reports, the investment round is in its early stages. The company’s goal is to obtain $200 million to $250 million to compete in the EV...

Digital wellness startup Mojorcare bags USD 20 Mn in Series A funding
Digital wellness startup Mojorcare bags USD 20 Mn in Series A funding
By Mateen Dalal

Mojocare, a wellness and health startup has reportedly raised USD 20.6 million in a Series A round of funding which was led by B Capital Group and saw participation from existing investors including Sequoia India’s Surge, Better Capital, and Ch...